Liontrust's take15 Apr 2022 10:30
Liontrust: Fever-Tree onshoring will support growth
Fever-Tree (FEVR) is supporting its growth plans by investing in US domestic operations after the pandemic highlighted the fragility of global supply chains, says Liontrust’s Chris Field.
In an insight letter for his £394m Liontrust UK Focus fund, Field, who joined Liontrust this month as part of its acquisition of Majedie Asset Management, highlighted the shift companies are making to onshore their operations after the Covid-19 pandemic made businesses wary of relying on offshore suppliers and manufacturers.
While businesses, like Fever-Tree, face a lengthy process in onshoring and the potential for ‘inflationary consequences’, there is a pay-off.
‘These pressures should ultimately be balanced by lower shipping costs, better management through tools such as artificial intelligence, and coordination between competitors, reduced disruption risk, and lower carbon emissions,’ he said.
‘Some of the world’s largest businesses are already making inroads, and this process is occurring at holdings such as Fever-Tree, with the business building domestic operations in the US to support its growth plans.’
Shares in Fever-Tree closed down 0.1% at £17.78 on Thursday, having slid by more than a third this year.